Hood River Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-352,344
| Closed | -$29.8M | – | 109 |
|
|
2018
Q4 | $29.8M | Buy |
352,344
+5,929
| +2% | +$502K | 1.76% | 13 |
|
|
2018
Q3 | $59.3M | Buy |
346,415
+7,938
| +2% | +$1.36M | 2.62% | 4 |
|
|
2018
Q2 | $43.7M | Buy |
338,477
+47,728
| +16% | +$6.17M | 2.25% | 8 |
|
|
2018
Q1 | $30M | Buy |
290,749
+5,352
| +2% | +$551K | 1.68% | 17 |
|
|
2017
Q4 | $24.4M | Buy |
285,397
+20,738
| +8% | +$1.77M | 1.41% | 22 |
|
|
2017
Q3 | $22.5M | Buy |
264,659
+5,900
| +2% | +$501K | 1.43% | 24 |
|
|
2017
Q2 | $19.6M | Buy |
258,759
+84,258
| +48% | +$6.38M | 1.35% | 29 |
|
|
2017
Q1 | $11.5M | Sell |
174,501
-108,393
| -38% | -$7.16M | 0.86% | 47 |
|
|
2016
Q4 | $17.9M | Buy |
282,894
+31,888
| +13% | +$2.02M | 1.56% | 19 |
|
|
2016
Q3 | $16M | Buy |
251,006
+181,239
| +260% | +$11.5M | 1.64% | 20 |
|
|
2016
Q2 | $5.19M | Buy |
+69,767
| New | +$5.19M | 0.69% | 63 |
|